CLINICAL RESEARCH: ATHEROMA COMPOSITION AND METABOLIC SYNDROME
Impact of Metabolic Syndrome on Tissue Characteristics of Angiographically Mild to Moderate Coronary LesionsIntegrated Backscatter Intravascular Ultrasound Study
Tetsuya Amano, MD, PhD*,*,
Tatsuaki Matsubara, MD, PhD ,
Tadayuki Uetani, MD, PhD*,
Michio Nanki, MD, PhD*,
Nobuyuki Marui, MD, PhD*,
Masataka Kato, MD*,
Kosuke Arai, MD*,
Kiminobu Yokoi, MD*,
Hirohiko Ando, MD*,
Hideki Ishii, MD ,
Hideo Izawa, MD, PhD and
Toyoaki Murohara, MD, PhD
* Department of Cardiology, Chubu-Rosai Hospital, Nagoya, Japan
Department of Internal Medicine, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Manuscript received August 31, 2006;
revised manuscript received October 30, 2006,
accepted November 6, 2006.
* Reprint requests and correspondence: Dr. Tetsuya Amano, Chubu-Rosai Hospital, Cardiology, Kohmei 1-10-6, Minato-ku, Nagoya 455-8530, Japan. (Email: amanot{at}med.nagoya-u.ac.jp).
Objectives: We assessed the impact of metabolic syndrome (MetS) on the tissue characteristics of coronary plaques using integrated backscatter intravascular ultrasound (IB-IVUS).
Background: Metabolic syndrome is associated with the increasing risk of cardiovascular disease.
Methods: We identified MetS by the definition of the National Cholesterol Education Program in Adult Treatment Panel III criterion. Non-target coronary lesions with mild to moderate stenosis were measured by conventional and IB-IVUS parameters using 40-MHz (motorized pullback 0.5 mm/s) intravascular catheter. A total of 20 IB-IVUS images were recorded at an interval of 0.5 mm for 10 mm length in each plaque. The 3-dimensional analyses were performed using commercially available software.
Results: The prevalence of MetS was 61 patients (50%) with 73 lesions (49%) among 122 patients with 148 lesions. Patients with MetS showed a significant increase in percentage lipid area (38 ± 19% vs. 30 ± 19%, p = 0.02) and percentage lipid volume (39 ± 17% vs. 33 ± 17%, p = 0.03), and they also showed a significant decrease in percentage of fibrous volume (57 ± 14% vs. 61 ± 13%, p = 0.03). Multivariate regression analysis after adjustment for potentially confounding risk factors showed that MetS remains correlated independently with the percentage of lipid volume (r = 0.223, p = 0.01). Logistic regression analysis after adjusting for confounding and non-MetS coronary risk factors showed that MetS (odds ratio 4.00, 95% confidence interval 1.33 to 12.0, p = 0.01) is proved to be an independent predictor of the lipid-rich plaque.
Conclusions: Metabolic syndrome is associated with lipid-rich plaques, contributing to the increasing risk of plaque vulnerability.
|
Abbreviations and Acronyms
| | ACS = acute coronary syndrome | | AMI = acute myocardial infarction | | ATP = Adult Treatment Panel | | CSA = cross-sectional area | | CVD = coronary vessel disease | | EEM = external elastic membrane | | %FV = percentage of fibrous volume | | IB-IVUS = integrated backscatter intravascular ultrasound | | IVUS = intravascular ultrasound | | LCSA = lumen cross-sectional area | | %LV = percentage of lipid volume | | MetS = metabolic syndrome | | NCEP = National Cholesterol Education Program | | PCI = percutaneous coronary intervention | | QCA = quantitative coronary angiography | | 3D = three-dimensional | | UAP = unstable angina pectoris |
|
This article has been cited by other articles:

|
 |

|
 |
 
T. Amano, T. Matsubara, T. Uetani, M. Nanki, N. Marui, M. Kato, T. Yoshida, K. Arai, K. Yokoi, H. Ando, et al.
Abnormal Glucose Regulation Is Associated With Lipid-Rich Coronary Plaque: Relationship to Insulin Resistance
J. Am. Coll. Cardiol. Img.,
January 1, 2008;
1(1):
39 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|